Trials / Unknown
UnknownNCT04123990
Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,100 (estimated)
- Sponsor
- VIFORFRANCE · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite its known prevalence in IBD, a recent study conducted with Prof. Cacoub (unpublished) on the national health insurance database showed that iron deficiency was an under-diagnosed and under-treated co-morbidity. In chronic diseases including IBD, Transferrin Saturation Factor is only performed in approximately 10% of cases, whereas it is recommended in inflammatory situations including IBD patients (HAS 2011). The objective of this study is therefore to obtain updated French data on the prevalence of iron deficiency in patients with IBD by applying the recommendations of ECCO and French Health High Authority (determination of ferritinemia and Transferrin Saturation Factor)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Iron status testing | Iron status testing |
Timeline
- Start date
- 2019-11-02
- Primary completion
- 2020-02-28
- Completion
- 2020-03-30
- First posted
- 2019-10-11
- Last updated
- 2019-10-11
Source: ClinicalTrials.gov record NCT04123990. Inclusion in this directory is not an endorsement.